
With a mifepristone safety review due by March and Senate control shifting in January, the FDA faces an extended stretch without a permanent leader.
Difelikefalin treats moderate-to-severe pruritus associated with chronic kidney disease in adults undergoing hemodialysis.
Medication Pearl of the Day: Korsuva (Difelikefalin)
Indication: Difelikefalin is a kappa opioid receptor agonist indicated for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD-aP) in adults undergoing hemodialysis (HD).
Insight:
Sources:






